A detailed history of California Public Employees Retirement System transactions in United Therapeutics Corp stock. As of the latest transaction made, California Public Employees Retirement System holds 211,822 shares of UTHR stock, worth $78.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
211,822
Previous 220,282 3.84%
Holding current value
$78.5 Million
Previous $70.2 Million 8.17%
% of portfolio
0.05%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$311.04 - $363.55 $2.63 Million - $3.08 Million
-8,460 Reduced 3.84%
211,822 $75.9 Million
Q2 2024

Aug 14, 2024

SELL
$228.26 - $319.04 $8.32 Million - $11.6 Million
-36,454 Reduced 14.2%
220,282 $70.2 Million
Q1 2024

Apr 30, 2024

SELL
$210.76 - $249.51 $46,999 - $55,640
-223 Reduced 0.09%
256,736 $59 Million
Q4 2023

Feb 01, 2024

SELL
$214.88 - $256.94 $127,208 - $152,108
-592 Reduced 0.23%
256,959 $56.5 Million
Q3 2023

Nov 02, 2023

BUY
$211.82 - $248.24 $611,524 - $716,668
2,887 Added 1.13%
257,551 $58.2 Million
Q2 2023

Aug 09, 2023

BUY
$205.19 - $232.99 $413,047 - $469,008
2,013 Added 0.8%
254,664 $56.2 Million
Q1 2023

May 12, 2023

BUY
$212.99 - $276.17 $16.2 Million - $21 Million
76,132 Added 43.13%
252,651 $56.6 Million
Q4 2022

Feb 08, 2023

BUY
$205.95 - $280.43 $15.1 Million - $20.6 Million
73,479 Added 71.31%
176,519 $49.1 Million
Q3 2022

Nov 09, 2022

BUY
$203.3 - $244.17 $2.59 Million - $3.11 Million
12,731 Added 14.1%
103,040 $21.6 Million
Q2 2022

Aug 10, 2022

SELL
$174.81 - $241.14 $1.02 Million - $1.4 Million
-5,826 Reduced 6.06%
90,309 $21.3 Million
Q1 2022

May 04, 2022

SELL
$166.16 - $213.96 $764,502 - $984,429
-4,601 Reduced 4.57%
96,135 $17.2 Million
Q4 2021

Feb 10, 2022

SELL
$184.32 - $216.08 $710,369 - $832,772
-3,854 Reduced 3.68%
100,736 $21.8 Million
Q3 2021

Nov 10, 2021

SELL
$179.86 - $214.88 $308,639 - $368,734
-1,716 Reduced 1.61%
104,590 $19.3 Million
Q2 2021

Aug 13, 2021

SELL
$170.47 - $211.93 $1.06 Million - $1.32 Million
-6,217 Reduced 5.53%
106,306 $19.1 Million
Q1 2021

May 14, 2021

SELL
$153.94 - $174.85 $429,492 - $487,831
-2,790 Reduced 2.42%
112,523 $18.8 Million
Q4 2020

Feb 02, 2021

BUY
$101.87 - $151.79 $1.17 Million - $1.75 Million
11,518 Added 11.1%
115,313 $17.5 Million
Q3 2020

Nov 05, 2020

BUY
$99.9 - $121.13 $292,307 - $354,426
2,926 Added 2.9%
103,795 $10.5 Million
Q2 2020

Aug 12, 2020

BUY
$92.74 - $125.82 $223,874 - $303,729
2,414 Added 2.45%
100,869 $12.2 Million
Q1 2020

May 12, 2020

SELL
$79.39 - $115.35 $396,950 - $576,750
-5,000 Reduced 4.83%
98,455 $9.34 Million
Q4 2019

Jan 27, 2020

SELL
$78.31 - $95.34 $982,868 - $1.2 Million
-12,551 Reduced 10.82%
103,455 $9.11 Million
Q3 2019

Oct 31, 2019

BUY
$74.85 - $85.99 $1.53 Million - $1.75 Million
20,387 Added 21.32%
116,006 $9.25 Million
Q2 2019

Aug 15, 2019

SELL
$76.06 - $120.81 $4.44 Million - $7.05 Million
-58,329 Reduced 37.89%
95,619 $7.46 Million
Q1 2019

May 03, 2019

SELL
$107.15 - $126.84 $1.41 Million - $1.67 Million
-13,171 Reduced 7.88%
153,948 $18.1 Million
Q4 2018

Feb 08, 2019

SELL
$101.4 - $128.73 $1.1 Million - $1.39 Million
-10,808 Reduced 6.07%
167,119 $18.2 Million
Q3 2018

Nov 13, 2018

SELL
$113.81 - $129.46 $1.84 Million - $2.09 Million
-16,177 Reduced 8.33%
177,927 $22.8 Million
Q2 2018

Aug 15, 2018

BUY
$101.14 - $118.31 $1.59 Million - $1.86 Million
15,752 Added 8.83%
194,104 $22 Million
Q1 2018

May 11, 2018

BUY
$107.21 - $151.94 $1.62 Million - $2.3 Million
15,142 Added 9.28%
178,352 $20 Million
Q4 2017

Feb 06, 2018

BUY
$118.58 - $151.28 $3.49 Million - $4.45 Million
29,417 Added 21.99%
163,210 $24.1 Million
Q3 2017

Nov 15, 2017

BUY
$114.6 - $136.81 $15.3 Million - $18.3 Million
133,793
133,793 $15.7 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.